- BS 1989, PhD 1995 Purdue University
- Patent for a novel freeze dried formulation for ERAXIS™ (anidulafungin) and successful defense of the patent in the European Patent Court
- Supported the development of a novel oncology drug that became a block-buster product while living in Hamburg, Germany for three months
- Presented at the Ministry of Health and Welfare – National Institute of Health on freeze drying technology in Kobe and Tokyo
- Received the Lilly Research Laboratories 2014 Top 100 Innovator Award for Implementation of Sterile Compounding to support clinical trials
- Leading a great team of development scientists to develop novel ultra-rapid insulin formulations
Dr. Nathaniel (Nate) Milton PhD, RPh received his BS in Pharmacy in 1989 and his PhD in Industrial and Physical Pharmacy in 1995 from the Purdue University College of Pharmacy. He retired from Eli Lilly and Company after 28 years of service where his last role was as a Research Advisor in Biopharmaceutical Product Development. In this role, Nathaniel led formulation development teams responsible for developing small and large molecule (proteins, peptides, and insulins) parenteral formulations, supporting technology transfer to clinical trial and commercial manufacturing facilities, lyophilization research and establishing processes for sterile extemporaneous compounding to enable early phase clinical trials.
Nathaniel recently joined Exelead Biopharmaceuticals as a Senior Scientist providing technical support to manufacturing, quality control and product development. His memberships and professional affiliations have included the American Association of Pharmaceutical Scientists (AAPS), the Parenteral Drug Association (PDA), Purdue’s College of Pharmacy Diversity and Inclusion Committee and the Dean’s Advisory Council. He is also an Adjunct Faculty member in the Department of Industrial and Physical Pharmacy. Nathaniel volunteers at the Rophe Free Clinic in Indianapolis where he practices community pharmacy and mentors pharmacy interns.